Roivant Sciences Ltd.

NASDAQ:ROIV

11.87 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Operating Activities:
Net Income 95.297-182.4965,072.665-331.118-327.845-60.862-384.896-315.921-353.784-291.313-306.085-225.64-101.078-563.161-275.597-53.498-7.977-59.676
Depreciation & Amortization 4.8835.2255.3855.5875.8395.9535.1517.7532.6781.7061.372.856000000
Deferred Income Tax 05,301.884-5,413.988104.547.564-32.46200-2.678000000000
Stock Based Compensation 50.19146.72454.32549.31849.2625.27757.73161.97972.79477.15971.216397.31219.26939.44217.32413.91414.27880.88
Change In Working Capital -68.73515.95521.19517.127-35.24221.1822.74130.537-48.11537.568-101.98992.071-11.931106.779-21.1650.31-13.9860
Accounts Receivables 000000000000000000
Change In Inventory 000000000000000000
Change In Accounts Payables -25.26720.887-8.345-1.79811.94-9.6117.19626.225-19.45111.71-52.81762.853-6.3436.454-2.673-7.537.5010
Other Working Capital -43.468-4.93229.5418.925-47.18230.793-4.4554.312-28.66425.858-49.17229.218-5.588100.325-18.4927.84-21.4870
Other Non Cash Items -189.24137.4649.966-41.88150.492-138.17696.6826.02277.02329.11768.364-384.339-47.43310.87342.579-58.771-103.482-25.564
Operating Cash Flow -192.829-108.457-210.452-196.427-249.932-179.088-222.593-189.63-252.082-147.469-268.494-120.596-141.17-106.067-236.859-98.045-111.167-85.24
Investing Activities:
Investments In Property Plant And Equipment -0.965-0.349-0.355-0.275-0.403-1.622-0.508-3.101-7.459-6.263-6.073-2.761-2.339-4.09-0.107-1.303-0.306-1.802
Acquisitions Net 0-0.8045,233.396-36.1790114.561-3.091-3.615000000021.439-19.0850
Purchases Of Investments 000000000000000-22-6.250
Sales Maturities Of Investments 05,233.3960000000320.17-443.754320.17000000
Other Investing Activites 08.0815,233.3960.0030.5080.6140.088-140.1360-319.609443.754320.17000-0.561-25.335-46.049
Investing Cash Flow -0.9656.9285,233.041-36.4510.105113.553-3.511-146.852-7.459-5.702-6.073317.409-2.339-4.09-0.107-1.864-25.641-47.851
Financing Activities:
Debt Repayment -1.829-7.665-7.662-7.57-7.808-8.036-7.423-7.341-150.305-0.032-21.59-7.243-21.5900000
Common Stock Issued 2.2713.655238.733221.52821.028219.807163.03100313.42400099-0.261175.837181.180
Common Stock Repurchased -648.385222.2220-215.528-5.743-1.439-1.1130-8.3292.2470-2.2470000-0.113-990.821
Dividends Paid 0-60-6-60000000000000
Other Financing Activities -12.673-28.6145.568215.4426-1.439-1.113-7.341-8.3291.0713.168303.93431.8-0.2860.7250.119-0.05-1,100.087
Financing Cash Flow -660.616-32.624236.639207.8727.477210.332154.495-7.341141.9761.07-8.422303.93410.2198.7140.464175.956181.13-1,100.087
Other Information:
Effect Of Forex Changes On Cash -2.74-0.8553.042-1.454-0.1176.281000000000000
Net Change In Cash -857.15-135.0085,262.27-26.46-242.467151.078-71.609-343.823-117.565-152.101-282.989500.747-133.299-11.443-236.50276.04744.322-1,233.178
Cash At End Of Period 5,683.9236,550.456,685.4581,423.1881,449.6481,692.1151,541.0371,612.6461,956.4692,074.0342,226.1352,509.1242,008.3772,141.6762,153.1192,389.6212,313.5742,269.252